UCB-Derived CD11c+ Dendritic Cells for Cancer Treatment
Researchers are investigating umbilical cord blood (UCB)-derived CD11c+ dendritic cells as a potent immunotherapy for cancer. By leveraging these specialized immune cells to recognize and attack malignant tumors, this approach ... Read More